W, B., CR, H., & J, J. (2024). Predictable excess hepatotoxicity in the SimpliciTB trial. The Lancet. Infectious diseases, 24(12), e727. https://doi.org/10.1016/S1473-3099(24)00598-X
Chicago Style (17th ed.) CitationW, Burman, Horsburgh CR, and Johnston J. "Predictable Excess Hepatotoxicity in the SimpliciTB Trial." The Lancet. Infectious Diseases 24, no. 12 (2024): e727. https://doi.org/10.1016/S1473-3099(24)00598-X.
MLA (9th ed.) CitationW, Burman, et al. "Predictable Excess Hepatotoxicity in the SimpliciTB Trial." The Lancet. Infectious Diseases, vol. 24, no. 12, 2024, p. e727, https://doi.org/10.1016/S1473-3099(24)00598-X.
Warning: These citations may not always be 100% accurate.